Table 3.
Follow-up
Follow-up | ||
---|---|---|
Median follow-up (months, range) | 16 | 5–22 |
Follow-up modality | ||
MRI only | 11 | 57% |
MRI + CT | 7 | 37% |
MRI + 18FFDG-PET | 1 | 5% |
Patients with tumor recurrence (concerning the ablated tumor) | 0 | 0% |
Patients with new liver tumors (other than ablated tumors) | 6 | 32% |
Patients with progressive or new tumors outside the liver | 3 | 16% |
Complications | ||
Complicated procedures | 2 | 10% |
Uncomplicated procedures | 17 | 90% |
Grade 2 | 1 | 5% |
Grade 3 | 1 | 5% |